Neurocrine Biosciences

NBIX

NBIX
Neurocrine Biosciences Stock Quote
$110.59 -$0.84 -0.8%
BATS BZX Real Time Price as of December 13, 2019, 4:00 p.m. EST View Interactive NBIX Charts

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis.

News & Analysis: Neurocrine Biosciences

The Fool has written over 100 articles on Neurocrine Biosciences.

All

Market Moves

Earnings











Interactive Chart